4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
A clinically detailed review of liraglutide dosing in East Asian patients, covering pharmacokinetics, ethnicity-stratified trial data, BMI thresholds, and pharmacogenomic considerations including CYP2C19 and CYP2D6 polymorphisms.
Evidence-based review of liraglutide response differences in Black and African ancestry populations, including ethnicity-stratified trial data, pharmacogenomic factors, and clinical dosing guidance.
Evidence-based review of how liraglutide safety, pharmacogenomics, and dosing considerations differ for Hispanic and Latino populations, with ethnicity-stratified trial data and clinical guidance.
A guide to liraglutide dosing considerations for South Asian patients, covering ethnicity-adjusted BMI thresholds, cardiovascular risk context, pharmacokinetic reasoning, and where the evidence runs out.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.